FDA updates needlestick rules:
This article was originally published in Clinica
Executive Summary
The US FDA has updated its December 2002 guidance document on what should be included in a pre-market notification for anti-needlestick products. Most medical devices that include sharps injury prevention features are intravascular administration sets, piston syringes or hypodermic single-lumen needles. The guidance pertains only to the sharps injury prevention feature and does not cover the FDA's recommendations for the device itself, the agency said.